Award
NIH Reporter #3OT3HL152932-01S2
CureSC Manufacturing Resource Platform
Recipient
Beckman Research Institute / City of Hope, Duarte, CA, United States
Award Amount
$1,785,617.00
Ceiling
$1,785,617.00
Awarded
August 18, 2023
Identifier
3OT3HL152932-01S2
This award supports the development of a manufacturing resource platform for SCD gene therapies, including needs assessment, consortium formation, and assay development, led by City of Hope in collaboration with NHLBI.
Description
An Other Transaction Agreement award to establish a manufacturing resource platform for Sickle Cell Disease (SCD) therapies. The project involves conducting a needs assessment, creating a consortium of manufacturers, and developing a strategy for cell and vector production, assay development, and capacity building.